InVivo Biosystems specializes in genome editing and preclinical research for neurological, metabolic, and rare monogenic diseases.
InVivo Biosystems's investors include Rogue Venture Partners, Oregon Venture Fund, Portland Seed Fund, National Institutes of Health, Cascade Seed Fund.
InVivo Biosystems is headquartered in Eugene, United States.
InVivo Biosystems specializes in genome editing and preclinical research for neurological, metabolic, and rare monogenic diseases.
InVivo Biosystems is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"InVivo Biosystems — Funding & Investors." VCBacked, April 13, 2025, https://www.vcbacked.co/company/invivo-biosystems. Accessed August 14, 2026.
VCBacked. (2025). InVivo Biosystems — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/invivo-biosystems
{{cite web |title=InVivo Biosystems — Funding & Investors |url=https://www.vcbacked.co/company/invivo-biosystems |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated